Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 18:04 (646 d 06:18 ago) – Posting: # 22419
Views: 1,973

Dear Loky do

❝ is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?


You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,550 posts in 4,724 threads, 1,606 registered users;
18 visitors (0 registered, 18 guests [including 10 identified bots]).
Forum time: 23:22 CET (Europe/Vienna)

That which is static and repetitive is boring.
That which is dynamic and random is confusing.
In between lies art.    John Locke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5